Literature DB >> 6607314

Thymic cytotoxic T lymphocytes are primed in vivo to minor histocompatibility antigens.

P J Fink, M J Bevan, I L Weissman.   

Abstract

Potent cytotoxic T lymphocyte (CTL) activity can be derived from cultures of thymocyte responders and minor H different spleen cell stimulators. As is the case of the spleen cell response previously reported, this cytotoxic activity requires in vivo priming. We performed several experiments designed to determine whether the in vivo priming effect is due to the in situ priming of the thymocyte CTL precursors, to contamination of thymus cell preparations with cells of neighboring lymph nodes, or to the appearance in the thymus of antigen-reactive peripheral T cells. We show by depletion of peripheral cells with antilymphocyte serum and part body irradiation that recent thymic immigrants derived from the bone marrow contribute to the primed thymic response. Thymic CTL were primed in animals in which peripheral T cell responses were completely eliminated by repeated treatment in vivo with monoclonal anti-Thy-1 reagents. Primed, antigen-activated lymph node cells were also demonstrated to contribute to the thymus-derived CTL response. Thus, the minor H-specific thymic CTL response is due both to in situ priming and the immigration of activated peripheral T cells. We discuss the possible significance for models of T cell differentiation of the presence within the thymus of antigen and antigen-reactive mature T cells.

Mesh:

Substances:

Year:  1984        PMID: 6607314      PMCID: PMC2187221          DOI: 10.1084/jem.159.2.436

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  32 in total

Review 1.  Experimental thymology has come of age.

Authors:  J F Miller
Journal:  Thymus       Date:  1979-09

2.  An in vivo assay for thymus-homing bone marrow cells.

Authors:  F Lepault; I L Weissman
Journal:  Nature       Date:  1981 Sep 10-16       Impact factor: 49.962

Review 3.  The influence of thymus H-2 antigens on the specificity of maturing killer and helper cells.

Authors:  M J Bevan; P J Fink
Journal:  Immunol Rev       Date:  1978       Impact factor: 12.988

4.  A new model for investigations of T-cell functions in mice: differential immunosuppressive effects of two monoclonal anti-Thy-1.2 antibodies.

Authors:  H G Opitz; U Opitz; G Hewlett; H D Schlumberger
Journal:  Immunobiology       Date:  1982-02       Impact factor: 3.144

5.  Effects of cytotoxic monoclonal antibody specific for T200 glycoprotein on functional lymphoid cell populations.

Authors:  G Dennert; R Hyman; J Lesley; I S Trowbridge
Journal:  Cell Immunol       Date:  1980-08-01       Impact factor: 4.868

6.  Properties and applications of monoclonal antibodies directed against determinants of the Thy-1 locus.

Authors:  A Marshak-Rothstein; P Fink; T Gridley; D H Raulet; M J Bevan; M L Gefter
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

7.  Role of prethymic cells in acquisition of self-tolerance.

Authors:  H O Besedovsky; A del Rey; E Sorkin
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

8.  Tolerance of thymocytes to allogeneic I region determinants encountered prethymically. Evidence for expression of anti-Ia receptors by T cell precursors before their entry into the thymus.

Authors:  S M Bradley; P J Morrissey; S O Sharrow; A Singer
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

9.  Bone marrow origin of Ia-positive cells in the medulla rat thymus.

Authors:  A N Barclay; G Mayrhofer
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

10.  Phenotypic and functional properties of murine thymocytes. I. Precursors of cytolytic T lymphocytes and interleukin 2-producing cells are all contained within a subpopulation of "mature" thymocytes as analyzed by monoclonal antibodies and flow microfluorometry.

Authors:  R Ceredig; A L Glasebrook; H R MacDonald
Journal:  J Exp Med       Date:  1982-02-01       Impact factor: 14.307

View more
  30 in total

1.  Antibody which defines a subset of bone marrow cells that can migrate to thymus.

Authors:  H C O'Neill
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

2.  Thymic output in aged mice.

Authors:  J Scott Hale; Tamar E Boursalian; Gail L Turk; Pamela J Fink
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-22       Impact factor: 11.205

Review 3.  Thymic stromal cell specialization and the T-cell receptor repertoire.

Authors:  D Lo; C R Reilly; L C Burkly; J DeKoning; T M Laufer; L H Glimcher
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

4.  Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients.

Authors:  A Melms; B C Schalke; T Kirchner; H K Müller-Hermelink; E Albert; H Wekerle
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

5.  L-selectin and alpha 4 beta 7 integrin homing receptor pathways mediate peripheral lymphocyte traffic to AKR mouse hyperplastic thymus.

Authors:  S A Michie; P R Streeter; E C Butcher; R V Rouse
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

Review 6.  Re-entry of mature T cells to the thymus: an epiphenomenon?

Authors:  Jonathan Sprent; Charles D Surh
Journal:  Immunol Cell Biol       Date:  2008-12-02       Impact factor: 5.126

7.  T cells home to the thymus and control infection.

Authors:  Claudia Nobrega; Cláudio Nunes-Alves; Bruno Cerqueira-Rodrigues; Susana Roque; Palmira Barreira-Silva; Samuel M Behar; Margarida Correia-Neves
Journal:  J Immunol       Date:  2013-01-11       Impact factor: 5.422

8.  The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.

Authors:  E Meinl; W E Klinkert; H Wekerle
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

9.  MCP-1/CCR2 interactions direct migration of peripheral B and T lymphocytes to the thymus during acute infectious/inflammatory processes.

Authors:  Deborah L Hodge; Della Reynolds; Fabio M Cerbán; Silvia G Correa; Natalia S Baez; Howard A Young; Maria Cecilia Rodriguez-Galan
Journal:  Eur J Immunol       Date:  2012-08-15       Impact factor: 5.532

10.  Enhanced expansion of the thymic CD8+ cell subset as a potential mechanism for the generation of enhanced antitumor cytotoxicity by thymocytes from low-dose melphalan-treated MOPC-315 tumor bearers.

Authors:  M M Bartik; B A Baumgartel-Scofield; M B Mokyr
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.